| Dr Joseph B Stoklosa, MD | |
|
115 Mill St, Belmont, MA 02478-1064 | |
| (617) 855-3987 | |
| (617) 855-2895 |
| Full Name | Dr Joseph B Stoklosa |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 17 Years |
| Location | 115 Mill St, Belmont, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043415565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | L-231830 (Massachusetts) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 239465 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Mclean Hospital Corporation | 9436040961 | 139 |
News Archive
Many of today's technological innovations from the iPhone to electric motors for hybrid cars require the use of materials - elements - that are scarce or difficult to obtain. As demand for these devices grows, the problem of dwindling critical element supplies must be addressed.
Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
› Verified 2 days ago
| Entity Name | The Mclean Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114979580 PECOS PAC ID: 9436040961 Enrollment ID: O20040323001228 |
News Archive
Many of today's technological innovations from the iPhone to electric motors for hybrid cars require the use of materials - elements - that are scarce or difficult to obtain. As demand for these devices grows, the problem of dwindling critical element supplies must be addressed.
Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph B Stoklosa, MD 115 Mill St, Belmont, MA 02478-1064 Ph: (617) 855-3987 | Dr Joseph B Stoklosa, MD 115 Mill St, Belmont, MA 02478-1064 Ph: (617) 855-3987 |
News Archive
Many of today's technological innovations from the iPhone to electric motors for hybrid cars require the use of materials - elements - that are scarce or difficult to obtain. As demand for these devices grows, the problem of dwindling critical element supplies must be addressed.
Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.
Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
› Verified 2 days ago
Evan D Murray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 115 Mill St, Mclean Hospital, Belmont, MA 02478 Phone: 617-855-2354 Fax: 617-855-3731 | |
Stephane Poulin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Mclean Hospital, 115 Mill Street, Belmont, MA 02478 Phone: 617-855-2183 | |
Dr. Emily J Deringer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3621 | |
Dr. Marni Joy Chanoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3937 | |
Prof. Bruce Michael Cohen, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3227 Fax: 617-855-3670 | |
John D Gambill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29 Stults Rd, Belmont, MA 02478 Phone: 617-489-2645 | |
Ashley Beaulieu, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3117 |